Other analysts have also recently issued research reports about the company. Zacks Investment Research upgraded AptarGroup from a “sell” rating to a “hold” rating and set a $123.00 target price on the stock in a report on Monday, October 14th. KeyCorp reiterated a “hold” rating on shares of AptarGroup in a report on Thursday, August 1st. Wells Fargo & Co decreased their price target on AptarGroup from $120.00 to $115.00 and set a “market perform” rating on the stock in a report on Tuesday. UBS Group raised their price target on AptarGroup from $115.00 to $122.00 and gave the company a “neutral” rating in a report on Thursday, August 1st. Finally, Morgan Stanley decreased their price target on AptarGroup from $144.00 to $136.00 and set an “overweight” rating on the stock in a report on Monday. Two investment analysts have rated the stock with a sell rating, four have issued a hold rating and five have issued a buy rating to the stock. AptarGroup currently has an average rating of “Hold” and an average price target of $119.29.
Shares of ATR stock traded down $0.40 during trading hours on Wednesday, hitting $109.00. 303,487 shares of the company’s stock were exchanged, compared to its average volume of 243,203. The stock’s 50-day moving average is $116.20 and its 200-day moving average is $118.16. The company has a debt-to-equity ratio of 0.73, a current ratio of 2.04 and a quick ratio of 1.45. The stock has a market cap of $6.95 billion, a price-to-earnings ratio of 27.25, a price-to-earnings-growth ratio of 2.67 and a beta of 0.72. AptarGroup has a 52 week low of $88.26 and a 52 week high of $126.19.
In related news, Director Joanne C. Dr Smith sold 5,749 shares of the firm’s stock in a transaction dated Monday, September 23rd. The stock was sold at an average price of $118.65, for a total value of $682,118.85. Following the transaction, the director now owns 20,053 shares in the company, valued at $2,379,288.45. The transaction was disclosed in a document filed with the SEC, which is available through this hyperlink. 3.00% of the stock is owned by company insiders.
Institutional investors and hedge funds have recently modified their holdings of the business. Krane Funds Advisors LLC bought a new position in AptarGroup during the second quarter worth about $25,000. NumerixS Investment Technologies Inc bought a new position in AptarGroup during the second quarter worth about $37,000. Cullen Frost Bankers Inc. bought a new position in AptarGroup during the second quarter worth about $44,000. Point72 Hong Kong Ltd boosted its holdings in AptarGroup by 200.8% during the second quarter. Point72 Hong Kong Ltd now owns 713 shares of the industrial products company’s stock worth $89,000 after buying an additional 476 shares during the last quarter. Finally, Quest Capital Management Inc. ADV bought a new position in AptarGroup during the third quarter worth about $88,000. Hedge funds and other institutional investors own 88.70% of the company’s stock.
AptarGroup, Inc provides a range of packaging, dispensing, and sealing solutions primarily for the beauty, personal care, home care, prescription drug, consumer health care, injectable, and food and beverage markets. The company operates through three segments: Beauty + Home, Pharma, and Food + Beverage.
To view ValuEngine’s full report, visit ValuEngine’s official website.
Receive News & Ratings for AptarGroup Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for AptarGroup and related companies with MarketBeat.com's FREE daily email newsletter.